# Apnar Pharma Private Limited – FDA Inspection, Sep 11, 2026

Source: https://www.keypedia.com/records/fda_inspections/apnar-pharma-private-limited/3b244891-8ccd-4082-a092-497c806a79c1
Source feed: FDA_Inspections

> FDA inspection 1335180 of Apnar Pharma Private Limited, September 11, 2026. 1 citation. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1335180
- Company Name: Apnar Pharma Private Limited
- Inspection Date: 2026-09-11
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 1

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/tanya-r-syffrard/a78a42b3-6cef-46d9-9698-ec6082956477)

Company: https://www.keypedia.com/companies/apnar-pharma-private-limited/14c28e0f-fd47-4c3a-80c3-f85e25d7ea0a

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8